{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:27:14Z","timestamp":1792740434999,"version":"4.5.0"},"reference-count":548,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1210\/er.2005-0015","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T12:50:22Z","timestamp":1144327822000},"page":"170-207","source":"Crossref","is-referenced-by-count":461,"title":["The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization"],"prefix":"10.1210","volume":"27","author":[{"given":"Nick S.","family":"Macklon","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine and Gynecology (N.S.M., B.C.J.M.F.), University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Stouffer","sequence":"additional","affiliation":[{"name":"Division of Reproductive Sciences (R.L.S.), Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon 97239-3098;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda C.","family":"Giudice","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology (L.C.G.), Stanford University School of Medicine, Stanford, California 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C. J. M.","family":"Fauser","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Gynecology (N.S.M., B.C.J.M.F.), University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041122403362400_R1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0950-3552(05)80310-4","article-title":"Induction of ovulation for assisted reproduction programmes.","volume":"4","author":"Oehninger","year":"1990","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"2019041122403362400_R2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1043-2760(03)00075-4","article-title":"Reproductive biology and IVF: ovarian stimulation and luteal phase consequences.","volume":"14","author":"Fauser","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"2019041122403362400_R3","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(05)66478-1","article-title":"Multiple birth resulting from ovarian stimulation for subfertility treatment.","volume":"365","author":"Fauser","year":"2005","journal-title":"Lancet"},{"key":"2019041122403362400_R4","first-page":"71","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences.","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R5","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/humrep\/14.11.2681","article-title":"Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks.","volume":"14","author":"Fauser","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/305707a0","article-title":"Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo.","volume":"305","author":"Trounson","year":"1983","journal-title":"Nature"},{"key":"2019041122403362400_R7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0015-0282(16)48029-5","article-title":"Two pregnancies following transfer of intact frozen-thawed embryos.","volume":"42","author":"Zeilmaker","year":"1984","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses.","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R9","first-page":"200","article-title":"Initial and cyclic recruitment of ovarian follicles.","volume":"21","author":"McGee","year":"2000","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1095\/biolreprod35.1.68","article-title":"The effects of food restriction and hypophysectomy on numbers of primordial follicles and concentrations of hormones in rats.","volume":"35","author":"Meredith","year":"1986","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1095\/biolreprod57.5.1233","article-title":"Chronically elevated luteinizing hormone depletes primordial follicles in the mouse ovary.","volume":"57","author":"Flaws","year":"1997","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/17.1.88","article-title":"The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries.","volume":"17","author":"Barnes","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R13","first-page":"1471","article-title":"Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.","volume":"74","author":"Schoot","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0015-0282(00)00549-5","article-title":"Expression of transforming growth factor-\u03b1, epidermal growth factor, and epidermal growth factor receptor in follicles of human ovarian tissue before and after cryopreservation.","volume":"74","author":"Qu","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R15","first-page":"25","author":"Gougeon","year":"2004"},{"key":"2019041122403362400_R16","first-page":"600","article-title":"Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.","volume":"74","author":"Hall","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R17","first-page":"439","article-title":"Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition.","volume":"77","author":"Le Nestour","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0015-0282(16)46509-X","article-title":"The dominant ovarian follicle.","volume":"38","author":"Hodgen","year":"1982","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0015-0282(16)53821-7","article-title":"Growth patterns of nondominant ovarian follicles during the normal menstrual cycle.","volume":"54","author":"Pache","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0015-0282(16)57652-3","article-title":"Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle.","volume":"64","author":"Santbrink","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R21","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/13.6.1442","article-title":"Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years.","volume":"13","author":"Schipper","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R22","first-page":"1401","article-title":"Measurement of dimeric inhibin B throughout the human menstrual cycle.","volume":"81","author":"Groome","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0022-4731(87)90289-5","article-title":"A model for follicular selection and ovulation: lessons from superovulation.","volume":"27","author":"Baird","year":"1987","journal-title":"J Steroid Biochem"},{"key":"2019041122403362400_R24","first-page":"2645","article-title":"Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.","volume":"82","author":"Welt","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R25","first-page":"2163","article-title":"Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development.","volume":"84","author":"Welt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R26","first-page":"241","article-title":"Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.","volume":"77","author":"Stouffer","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R27","first-page":"756","article-title":"Activin-A inhibits progesterone production by macaque luteal cells in culture.","volume":"75","author":"Brannian","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1677\/joe.0.1420181","article-title":"Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion.","volume":"142","author":"Fraser","year":"1994","journal-title":"J Endocrinol"},{"key":"2019041122403362400_R29","first-page":"4002","article-title":"Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.","volume":"81","author":"Molskness","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R30","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1210\/endo-119-5-2025","article-title":"Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH.","volume":"119","author":"Zeleznik","year":"1986","journal-title":"Endocrinology"},{"key":"2019041122403362400_R31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1210\/jcem-72-4-912","article-title":"Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.","volume":"72","author":"Fluker","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/jcem-72-5-993","article-title":"Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.","volume":"72","author":"Hall","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R33","first-page":"228","article-title":"Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.","volume":"84","author":"Sullivan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/8.6.543","article-title":"The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction.","volume":"8","author":"Filicori","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R35","first-page":"45","author":"Zeleznik","year":"2004"},{"key":"2019041122403362400_R36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/edrv-16-6-765","article-title":"Follicle-stimulating isohormones: characterization and physiological relevance.","volume":"16","author":"Ulloa-Aguirre","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/jcem-67-3-465","article-title":"Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis.","volume":"67","author":"Padmanabhan","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R38","first-page":"885","article-title":"More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase.","volume":"76","author":"Wide","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R39","first-page":"1647","article-title":"Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle.","volume":"80","author":"Zambrano","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R40","first-page":"3208","article-title":"Mode of pulsatile follicle-stimulating hormone secretion in gonadal hormone-sufficient and -deficient women\u2014a clinical research center study.","volume":"81","author":"Booth Jr","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease.","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0015-0282(16)59467-9","article-title":"Regulation of human granulosa-luteal cell progesterone production and proliferation by gonadotropins and growth factors.","volume":"48","author":"Tapanainen","year":"1987","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R43","first-page":"2053","article-title":"Production of transforming growth factor-\u03b1 by normal and polycystic ovaries.","volume":"80","author":"Mason","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R44","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0006-2952(97)00477-2","article-title":"Regulation of cellular and system function by activin.","volume":"55","author":"Woodruff","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"2019041122403362400_R45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0303-7207(02)00053-9","article-title":"Recruitment and development of the follicle; the roles of the transforming growth factor-\u03b2 superfamily.","volume":"191","author":"Findlay","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122403362400_R46","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1210\/jcem-69-4-716","article-title":"Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells.","volume":"69","author":"Erickson","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R47","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0015-0282(16)54004-7","article-title":"Effect of insulin-like growth factor I on deoxyribonucleic acid synthesis in cultured human granulosa cells.","volume":"54","author":"Olsson","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1210\/jcem.74.4.1548349","article-title":"Hormonal regulation of the growth and steroidogenic function of human granulosa cells.","volume":"74","author":"Yong","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0015-0282(16)56580-7","article-title":"Insulin-like growth factor-II stimulates human granulosa-luteal cell proliferation in vitro.","volume":"61","author":"Di Blasio","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R50","first-page":"106","article-title":"The effects of growth factors and phorbol esters on steroid biosynthesis in isolated human theca interna and granulosa-lutein cells in long term culture.","volume":"79","author":"McAllister","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/humrep\/10.1.75","article-title":"Metabolic regulation of androgen production by human thecal cells in vitro.","volume":"10","author":"Nahum","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(16)55675-1","article-title":"Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.","volume":"59","author":"Bergh","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R53","first-page":"641","article-title":"Insulin-like growth factors and ovarian follicular development.","volume":"13","author":"Giudice","year":"1992","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R54","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/endo.132.2.8425504","article-title":"Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression.","volume":"132","author":"Maruo","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122403362400_R55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2265.1990.tb03888.x","article-title":"Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries.","volume":"33","author":"Mason","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122403362400_R56","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1095\/biolreprod48.3.552","article-title":"Epidermal growth factor and transforming growth factor-\u03b2 modulation of follicle-stimulating hormone-induced deoxyribonucleic acid synthesis in hamster preantral and early antral follicles.","volume":"48","author":"Roy","year":"1993","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R57","first-page":"1402","article-title":"Expression of inhibin\/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle.","volume":"77","author":"Roberts","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1210\/endo.137.2.8593790","article-title":"Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin.","volume":"137","author":"Miro","year":"1996","journal-title":"Endocrinology"},{"key":"2019041122403362400_R59","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1095\/biolreprod65.3.967","article-title":"Effect of activin A on in vitro development of rat preantral follicles and localization of activin A and activin receptor II.","volume":"65","author":"Zhao","year":"2001","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R60","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1210\/endo-129-6-3388","article-title":"Development-related effects of recombinant activin on steroid synthesis in rat granulosa cells.","volume":"129","author":"Miro","year":"1991","journal-title":"Endocrinology"},{"key":"2019041122403362400_R61","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/jcem-72-6-1206","article-title":"Effect of recombinant activin on androgen synthesis in cultured human thecal cells.","volume":"72","author":"Hillier","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/humupd\/dmg016","article-title":"Progesterone as a mediator of gonadotrophin action in the corpus luteum: beyond steroidogenesis.","volume":"9","author":"Stouffer","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R63","author":"Stouffer","year":"2005"},{"key":"2019041122403362400_R64","first-page":"201","author":"Bowen-Shauver","year":"2004"},{"key":"2019041122403362400_R65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/B978-0-12-039228-5.50016-4","article-title":"Corpus luteum of the nonhuman primate.","volume":"28","author":"Moudgal","year":"1984","journal-title":"Adv Vet Sci Comp Med"},{"key":"2019041122403362400_R66","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1210\/endo-126-5-2237","article-title":"Effect of reduced luteinizing hormone concentrations on corpus luteum function during the menstrual cycle of rhesus monkeys.","volume":"126","author":"Zeleznik","year":"1990","journal-title":"Endocrinology"},{"key":"2019041122403362400_R67","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1210\/jcem-72-4-912","article-title":"Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.","volume":"72","author":"Fluker","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R68","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(16)56932-5","article-title":"A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge.","volume":"62","author":"Leroy","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R69","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1210\/endo-121-2-612","article-title":"Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.","volume":"121","author":"Fraser","year":"1987","journal-title":"Endocrinology"},{"key":"2019041122403362400_R70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0015-0282(16)54537-3","article-title":"Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.","volume":"56","author":"Dubourdieu","year":"1991","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R71","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R72","first-page":"98","author":"Zelinski-Wooten","year":"2000"},{"key":"2019041122403362400_R73","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1210\/endo.133.6.8243314","article-title":"Induction of ovarian follicle luteinization by recombinant follicle-stimulating hormone.","volume":"133","author":"Tapanainen","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122403362400_R74","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/oxfordjournals.humrep.a136151","article-title":"Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys.","volume":"10","author":"Zelinski-Wooten","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R75","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0015-0282(16)49840-7","article-title":"Prevention of gonadotropin-releasing hormone antagonist induced luteal regression by concurrent exogenous pulsatile gonadotropin administration in monkeys.","volume":"46","author":"Collins","year":"1986","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1677\/joe.0.1280121","article-title":"Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey.","volume":"128","author":"Webley","year":"1991","journal-title":"J Endocrinol"},{"key":"2019041122403362400_R77","first-page":"342","article-title":"Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys.","volume":"84","author":"Duffy","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R78","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1073\/pnas.95.18.11002","article-title":"In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin.","volume":"95","author":"Zeleznik","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122403362400_R79","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1095\/biolreprod31.4.714","article-title":"Changing frequency of pulsatile luteinizing hormone and progesterone secretion during the luteal phase of the menstrual cycle of rhesus monkeys.","volume":"31","author":"Ellinwood","year":"1984","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R80","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1210\/endo-119-5-1964","article-title":"Effects of different gonadotropin pulse frequencies on corpus luteum function during the menstrual cycle of rhesus monkeys.","volume":"119","author":"Hutchison","year":"1986","journal-title":"Endocrinology"},{"key":"2019041122403362400_R81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/biolreprod\/8.2.246","article-title":"On the regulation of the primate corpus luteum.","volume":"8","author":"Knobil","year":"1973","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/molehr\/7.2.137","article-title":"Dominant expression and distribution of oestrogen receptor \u03b2 over oestrogen receptor \u03b1 in the human corpus luteum.","volume":"7","author":"Hosokawa","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"2019041122403362400_R83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/ENDO:11:1:23","article-title":"Androgen receptor mRNA expression in the rhesus monkey ovary.","volume":"11","author":"Duffy","year":"1999","journal-title":"Endocrine"},{"key":"2019041122403362400_R84","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/oxfordjournals.humrep.a137614","article-title":"Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression.","volume":"7","author":"Horie","year":"1992","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R85","first-page":"2135","article-title":"Follicle-stimulating hormone and luteinizing hormone\/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles.","volume":"82","author":"Christenson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R86","first-page":"3377","article-title":"Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40).","volume":"86","author":"Wulff","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R87","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1095\/biolreprod67.4.1305","article-title":"Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys.","volume":"67","author":"Hazzard","year":"2002","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R88","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/molehr\/5.12.1115","article-title":"Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval.","volume":"5","author":"Hazzard","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"2019041122403362400_R89","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI4814","article-title":"Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome.","volume":"102","author":"Levin","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041122403362400_R90","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/humrep\/deh132","article-title":"Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women.","volume":"19","author":"Molskness","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures.","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R92","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jcem-67-2-334","article-title":"Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle.","volume":"67","author":"Lessey","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R93","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0015-0282(16)53531-6","article-title":"Biochemical and immunohistochemical analyses of estrogen and progesterone receptors in the rhesus monkey uterus during the proliferative and secretory phases of artificial menstrual cycles.","volume":"53","author":"Okulicz","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.1991.tb37847.x","article-title":"Histology of the human endometrium: from birth to senescence.","volume":"622","author":"Ferenczy","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"2019041122403362400_R95","first-page":"2343","article-title":"Immunocytochemical localization of estrogen and progestin receptors in the baboon (Papio anubis) uterus during implantation and pregnancy.","volume":"130","author":"Hild-Petito","year":"1992","journal-title":"Endocrinology"},{"key":"2019041122403362400_R96","first-page":"541","author":"Brenner","year":"1994"},{"key":"2019041122403362400_R97","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/oxfordjournals.humrep.a138005","article-title":"Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages.","volume":"8","author":"Bergqvist","year":"1993","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R98","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","article-title":"Cloning of a novel receptor expressed in rat prostate and ovary.","volume":"93","author":"Kuiper","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122403362400_R99","first-page":"1370","article-title":"Estrogen receptor \u03b2, but not estrogen receptor \u03b1, is present in the vascular endothelium of the human and nonhuman primate endometrium.","volume":"86","author":"Critchley","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3181\/00379727-218-44298","article-title":"Estrogen receptor \u03b1 and progesterone receptor in the rhesus endometrium during the late secretory phase and menses.","volume":"218","author":"Okulicz","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"2019041122403362400_R101","first-page":"862","article-title":"Immunocytochemical study of progesterone receptors in the human endometrium during the menstrual cycle.","volume":"59","author":"Bergeron","year":"1988","journal-title":"Lab Invest"},{"key":"2019041122403362400_R102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.acthis.2004.02.005","article-title":"Immunohistochemical analysis of estrogen receptor \u03b1, estrogen receptor \u03b2 and progesterone receptor in normal human endometrium.","volume":"106","author":"Mylonas","year":"2004","journal-title":"Acta Histochem"},{"key":"2019041122403362400_R103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.1991.tb37859.x","article-title":"Estrogen and progestin receptors in the macaque endometrium.","volume":"622","author":"Brenner","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"2019041122403362400_R104","first-page":"291","article-title":"The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene.","volume":"54","author":"Giangrande","year":"1999","journal-title":"Recent Prog Horm Res"},{"key":"2019041122403362400_R105","first-page":"2963","article-title":"Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle.","volume":"84","author":"Mote","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"2019041122403362400_R106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humrep\/15.suppl_3.48","article-title":"Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma","volume":"15","author":"Mote","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R107","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0015-0282(16)58140-0","article-title":"Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation.","volume":"65","author":"Lessey","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R108","first-page":"235","author":"Cunha","year":"1997"},{"key":"2019041122403362400_R109","first-page":"3","author":"Cunha","year":"2002"},{"key":"2019041122403362400_R110","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1073\/pnas.94.12.6535","article-title":"Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium.","volume":"94","author":"Cooke","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122403362400_R111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy.","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R112","first-page":"171","author":"Ferenczy","year":"1995"},{"key":"2019041122403362400_R113","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/jrf.0.0660739","article-title":"Relationship of apical domes in the rabbit uterine epithelium during the peri-implantation period to endocytosis, apocrine secretion and fixation.","volume":"66","author":"Parr","year":"1982","journal-title":"J Reprod Fertil"},{"key":"2019041122403362400_R114","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/joe.0.1140319","article-title":"Scanning electron microscopy of postovulatory human endometrium in spontaneous cycles and cycles stimulated by hormone treatment.","volume":"114","author":"Martel","year":"1987","journal-title":"J Endocrinol"},{"issue":"Suppl 2","key":"2019041122403362400_R115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/humrep\/14.suppl_2.37","article-title":"Cell-surface morphological events relevant to human implantation","volume":"14","author":"Nikas","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R116","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/beog.2000.0117","article-title":"In vitro models of human blastocyst implantation.","volume":"14","author":"Bentin-Ley","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"2019041122403362400_R117","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2000.tb06244.x","article-title":"Surface morphology of the human endometrium. Basic and clinical aspects.","volume":"900","author":"Nikas","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"2019041122403362400_R118","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00129785-200404050-00003","article-title":"Microarray expression profiling reveals candidate genes for human uterine receptivity.","volume":"4","author":"Giudice","year":"2004","journal-title":"Am J Pharmacogenomics"},{"key":"2019041122403362400_R119","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/humrep\/14.3.787","article-title":"Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles.","volume":"14","author":"Nikas","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R120","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0015-0282(99)00137-5","article-title":"Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors.","volume":"71","author":"Develioglu","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0015-0282(16)54069-2","article-title":"The window of embryo transfer and the efficiency of human conception in vitro.","volume":"55","author":"Navot","year":"1991","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R122","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/00016348609155169","article-title":"Concentrations of steroid receptors in normal human endometrium in relation to the day of the menstrual cycle.","volume":"65","author":"Tamaya","year":"1986","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041122403362400_R123","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/jcem-67-1-80","article-title":"Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating.","volume":"67","author":"Garcia","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R124","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/humrep\/12.6.1293","article-title":"The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase\u2014an immunohistochemical study.","volume":"12","author":"Danielsson","year":"1997","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"2019041122403362400_R125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0015-0282(02)04830-6","article-title":"Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium","volume":"79","author":"Aghajanova","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/molehr\/8.9.871","article-title":"Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening.","volume":"8","author":"Carson","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"2019041122403362400_R127","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/endo.143.6.8885","article-title":"Global gene profiling in human endometrium during the window of implantation.","volume":"143","author":"Kao","year":"2002","journal-title":"Endocrinology"},{"key":"2019041122403362400_R128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/molehr\/gag004","article-title":"Determination of the transcript profile of human endometrium.","volume":"9","author":"Borthwick","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"2019041122403362400_R129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/molehr\/gag037","article-title":"Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology.","volume":"9","author":"Riesewijk","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"2019041122403362400_R130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2003-0020","article-title":"Molecular cues to implantation.","volume":"25","author":"Dey","year":"2004","journal-title":"Endocr Rev"},{"issue":"Suppl A","key":"2019041122403362400_R131","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.placenta.2004.01.014","article-title":"Implantation: embryonic signals and the modulation of the uterine environment\u2014a review","volume":"25","author":"Fazleabas","year":"2004","journal-title":"Placenta"},{"key":"2019041122403362400_R132","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/humupd\/dmg019","article-title":"Elucidating endometrial function in the post-genomic era.","volume":"9","author":"Giudice","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R133","author":"Hess","year":"2005"},{"key":"2019041122403362400_R134","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1098\/rspb.1963.0055","article-title":"A quantative and cytological study of germ cells in human ovaries.","volume":"158","author":"Baker","year":"1963","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"2019041122403362400_R135","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1095\/biolreprod50.3.653","article-title":"Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women.","volume":"50","author":"Gougeon","year":"1994","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R136","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ar.1092310208","article-title":"Morphometric study of the human neonatal ovary.","volume":"231","author":"Forabosco","year":"1991","journal-title":"Anat Rec"},{"key":"2019041122403362400_R137","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/jrf.0.0460055","article-title":"Follicular atresia in the infant human ovary.","volume":"46","author":"Himelstein-Braw","year":"1976","journal-title":"J Reprod Fertil"},{"key":"2019041122403362400_R138","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/oxfordjournals.humrep.a137570","article-title":"Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause.","volume":"7","author":"Faddy","year":"1992","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R139","first-page":"133","article-title":"Apoptosis: the biochemistry and molecular biology of programmed cell death.","volume":"14","author":"Schwartzman","year":"1993","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/jrf.0.0390053","article-title":"Follicular development in the infant human ovary.","volume":"39","author":"Lintern-Moore","year":"1974","journal-title":"J Reprod Fertil"},{"key":"2019041122403362400_R141","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-5122(81)90032-3","article-title":"Menstrual cyclicity and the pre-menopause.","volume":"3","author":"Treloar","year":"1981","journal-title":"Maturitas"},{"key":"2019041122403362400_R142","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1210\/jc.2002-020622","article-title":"Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development?","volume":"87","author":"Klein","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R143","first-page":"2742","article-title":"Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles.","volume":"81","author":"Klein","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R144","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(16)60615-5","article-title":"Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.","volume":"51","author":"Scott","year":"1989","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive ageing.","volume":"8","author":"Velde","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R146","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nature02316","article-title":"Germline stem cells and follicular renewal in the postnatal mammalian ovary.","volume":"428","author":"Johnson","year":"2004","journal-title":"Nature"},{"key":"2019041122403362400_R147","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2005.06.031","article-title":"Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood.","volume":"122","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"2019041122403362400_R148","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(16)60077-8","article-title":"The value of basal and\/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.","volume":"50","author":"Muasher","year":"1988","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R149","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0015-0282(16)54249-6","article-title":"Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.","volume":"55","author":"Toner","year":"1991","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0015-0282(02)04562-4","article-title":"Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization.","volume":"79","author":"Chuang","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R151","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/humrep\/17.8.2003","article-title":"Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment.","volume":"17","author":"Akande","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R152","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(02)04839-2","article-title":"Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization.","volume":"79","author":"Rooij","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R153","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0015-0282(03)00078-5","article-title":"Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis.","volume":"79","author":"Bancsi","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R154","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/humrep\/deh119","article-title":"Intercycle variability of ovarian reserve tests: results of a prospective randomized study.","volume":"19","author":"Kwee","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R155","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0015-0282(98)00080-6","article-title":"Elevated levels of basal estradiol-17\u03b2 predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization.","volume":"69","author":"Evers","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R156","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2265.1998.00482.x","article-title":"Serum inhibins A and B fall differentially as FSH rises in perimenopausal women.","volume":"48","author":"Burger","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122403362400_R157","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0015-0282(99)00193-4","article-title":"Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone.","volume":"72","author":"Seifer","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R158","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/humrep\/15.11.2341","article-title":"Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.","volume":"15","author":"Creus","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R159","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0015-0282(97)81865-1","article-title":"Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.","volume":"67","author":"Seifer","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R160","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/humrep\/14.11.2818","article-title":"Inhibin-B as a test of ovarian reserve for infertile women.","volume":"14","author":"Corson","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R161","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/humrep\/15.7.1499","article-title":"Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.","volume":"15","author":"Penarrubia","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R162","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/humrep\/17.6.1535","article-title":"Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome.","volume":"17","author":"Fawzy","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R163","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0015-0282(01)02983-1","article-title":"Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve.","volume":"77","author":"Bancsi","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R164","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0015-0282(99)00396-9","article-title":"Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility.","volume":"72","author":"Scheffer","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R165","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0015-0282(03)00664-2","article-title":"A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles.","volume":"80","author":"Frattarelli","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R166","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1067\/mob.2002.122146","article-title":"In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography.","volume":"186","author":"Tan","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122403362400_R167","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/00016348709022039","article-title":"Ultrasound measurement of the ovarian volume.","volume":"66","author":"Andolf","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041122403362400_R168","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0015-0282(16)57979-5","article-title":"Ovarian volume: a novel outcome predictor for assisted reproduction.","volume":"64","author":"Syrop","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R169","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/12.2.294","article-title":"Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response.","volume":"12","author":"Lass","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R170","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/humrep\/14.7.1752","article-title":"Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3.","volume":"14","author":"Syrop","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R171","first-page":"571","article-title":"Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.","volume":"81","author":"Lee","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R172","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","article-title":"Regulation of ovarian function: the role of anti-Mullerian hormone.","volume":"124","author":"Durlinger","year":"2002","journal-title":"Reproduction"},{"key":"2019041122403362400_R173","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary.","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"2019041122403362400_R174","first-page":"1006","article-title":"Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone.","volume":"8","author":"Clemente","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2019041122403362400_R175","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary.","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"2019041122403362400_R176","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging.","volume":"77","author":"Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R177","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R178","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R179","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve.","volume":"17","author":"Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/ajplegacy.1931.97.2.291","article-title":"The gonad-stimulating and the luteinizing hormones of the anterior lobe of the hypophysis.","volume":"97","author":"Fevold","year":"1931","journal-title":"Am J Physiol"},{"key":"2019041122403362400_R181","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01728562","article-title":"Hypophysenvorderlappen hormone und ovarialhormone im Harn von Schangeren.","volume":"6","author":"Ascheim","year":"1927","journal-title":"Klin Wochenschr"},{"key":"2019041122403362400_R182","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0002-9378(40)91248-0","article-title":"Endocrine therapy of functional ovarian failure.","volume":"40","author":"Hamblen","year":"1940","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122403362400_R183","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0015-0282(16)34445-4","article-title":"Induction of ovulation with human pituitary gonadotrophins.","volume":"13","author":"Gemzell","year":"1962","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R184","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmh044","article-title":"Historical perspectives in gonadotrophin therapy.","volume":"10","author":"Lunenfeld","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0015-0282(16)34082-1","article-title":"Observations on the use of a nonsteroidal estrogen antagonist: MER-25. II. Effects in endometrial hyperplasia and Stein-Leventhal syndrome.","volume":"12","author":"Kistner","year":"1961","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R186","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jama.1961.03040410001001","article-title":"Induction of ovulation with MRL\/41. Preliminary report.","volume":"178","author":"Greenblatt","year":"1961","journal-title":"JAMA"},{"key":"2019041122403362400_R187","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1095\/biolreprod25.3.667","article-title":"Agonistic and antagonistic effects of clomiphene citrate and its isomers.","volume":"25","author":"Clark","year":"1981","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R188","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0015-0282(98)00537-8","article-title":"Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women.","volume":"71","author":"Young","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R189","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2007-1022505","article-title":"Clomiphene citrate-initiated ovulation: a clinical update.","volume":"4","author":"Adashi","year":"1986","journal-title":"Sem Reprod Endocrinol"},{"key":"2019041122403362400_R190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0015-0282(16)60423-5","article-title":"Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.","volume":"51","author":"Polson","year":"1989","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R191","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0015-0282(16)57597-9","article-title":"Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome.","volume":"63","author":"Butzow","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R192","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/humrep\/13.9.2356","article-title":"Future use of clomiphene in ovarian stimulation. Will clomiphene persist in the 21st century?","volume":"13","author":"Tarlatzis","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R193","first-page":"2401","article-title":"[Decreased quality of cervix mucus under the influence of clomiphene: a meta-analysis].","volume":"141","author":"Roumen","year":"1997","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2019041122403362400_R194","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0015-0282(99)00509-9","article-title":"Effects of clomiphene citrate on the endometrium of regularly cycling women.","volume":"73","author":"Sereepapong","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)54048-5","article-title":"Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and\/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer.","volume":"55","author":"Shoham","year":"1991","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R196","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/oxfordjournals.humrep.a019182","article-title":"Incidence of spontaneous abortion in clomiphene pregnancies.","volume":"11","author":"Dickey","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R197","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women.","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041122403362400_R198","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-0528.1980.tb04610.x","article-title":"Establishing full-term human pregnancies using cleaving embryos grown in vitro.","volume":"87","author":"Edwards","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041122403362400_R199","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1126\/science.7221557","article-title":"Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle.","volume":"212","author":"Trounson","year":"1981","journal-title":"Science"},{"key":"2019041122403362400_R200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0015-0282(16)47289-4","article-title":"Concepts in human in vitro fertilization and embryo transfer.","volume":"40","author":"Lopata","year":"1983","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R201","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)47233-X","article-title":"Comparison of two clomiphene citrate dosage regimens for follicular recruitment in an in vitro fertilization program.","volume":"40","author":"Quigley","year":"1983","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R202","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0015-0282(16)47232-8","article-title":"Vital initiation of pregnancy (VIP) using human menopausal gonadotropin and human chorionic gonadotropin ovulation induction: phase II\u20131981.","volume":"40","author":"Wortham Jr","year":"1983","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R203","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0015-0282(16)47472-8","article-title":"The use of high-dose human menopausal gonadotropin in an in vitro fertilization program.","volume":"40","author":"Laufer","year":"1983","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R204","first-page":"965","author":"Fauser","year":"2004"},{"key":"2019041122403362400_R205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0015-0282(16)56059-2","article-title":"Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations.","volume":"60","author":"Stokman","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R206","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/meth.2000.0974","article-title":"Bioassays of gonadotropins.","volume":"21","author":"Christin-Maitre","year":"2000","journal-title":"Methods"},{"key":"2019041122403362400_R207","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/humrep\/14.6.1411","article-title":"What are the clinical benefits of recombinant gonadotrophins? Clinical efficacy of recombinant gonadotrophins.","volume":"14","author":"Balen","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R208","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1210\/mend-3-12-2011","article-title":"Expression of recombinant human choriogonadotropin in Chinese hamster ovary glycosylation mutants.","volume":"3","author":"Keene","year":"1989","journal-title":"Mol Endocrinol"},{"issue":"(Suppl 3)","key":"2019041122403362400_R209","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/humrep\/13.suppl_3.36","article-title":"Developments in human recombinant follicle stimulating hormone technology: are we going in the right direction?","volume":"13","author":"Fauser","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R210","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/S0021-9258(18)83656-0","article-title":"Expression of biologically active human follitropin in Chinese hamster ovary cells.","volume":"264","author":"Keene","year":"1989","journal-title":"J Biol Chem"},{"key":"2019041122403362400_R211","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0140-6736(92)92879-K","article-title":"Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome.","volume":"340","author":"Donderwinkel","year":"1992","journal-title":"Lancet"},{"key":"2019041122403362400_R212","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/0140-6736(92)93141-9","article-title":"First singleton term birth after ovarian superovulation with rhFSH.","volume":"340","author":"Devroey","year":"1992","journal-title":"Lancet"},{"key":"2019041122403362400_R213","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0140-6736(92)90770-4","article-title":"Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH.","volume":"339","author":"Germond","year":"1992","journal-title":"Lancet"},{"key":"2019041122403362400_R214","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/oxfordjournals.humrep.a135740","article-title":"A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.","volume":"10","author":"Out","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1472-6483(10)61709-9","article-title":"Improvement in consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic preparation.","volume":"6","author":"Hugues","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"2019041122403362400_R216","first-page":"1507","article-title":"Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study.","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R217","first-page":"2607","article-title":"Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R218","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0015-0282(01)01803-9","article-title":"Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG.","volume":"75","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R219","article-title":"Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception.","author":"Al Inany","year":"2005","journal-title":"Cochrane Database Syst"},{"key":"2019041122403362400_R220","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.89.10.4304","article-title":"Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin \u03b2 subunit to the follitropin \u03b2 subunit.","volume":"89","author":"Fares","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122403362400_R221","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1210\/jc.2004-0668","article-title":"Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin \u03b1) in women with World Health Organization group II anovulatory infertility.","volume":"89","author":"Balen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R222","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1016\/S0021-9258(19)34163-8","article-title":"The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus.","volume":"246","author":"Schally","year":"1971","journal-title":"J Biol Chem"},{"key":"2019041122403362400_R223","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000301848","article-title":"Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor.","volume":"2","author":"Guillemin","year":"1971","journal-title":"Gynecol Invest"},{"key":"2019041122403362400_R224","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0196-9781(99)00130-8","article-title":"Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.","volume":"20","author":"Schally","year":"1999","journal-title":"Peptides"},{"key":"2019041122403362400_R225","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotropin-releasing-hormone-receptor antagonists.","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet"},{"key":"2019041122403362400_R226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0303-7207(00)00320-8","article-title":"Gonadotropin-releasing hormone activates mitogen-activated protein kinase in human ovarian and placental cells.","volume":"170","author":"Kang","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122403362400_R227","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/mob.2002.119633","article-title":"Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues.","volume":"186","author":"Volker","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122403362400_R228","first-page":"3815","article-title":"Luteinizing hormone-releasing hormone induces nuclear factor \u03baB-activation and inhibits apoptosis in ovarian cancer cells.","volume":"85","author":"Grundker","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R229","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-199448010-00005","article-title":"Gonadotrophin-releasing hormone agonists. A guide to use and selection.","volume":"48","author":"Filicori","year":"1994","journal-title":"Drugs"},{"key":"2019041122403362400_R230","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/978-1-4684-3474-3_75","article-title":"Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function.","volume":"112","author":"Labrie","year":"1979","journal-title":"Adv Exp Med Biol"},{"key":"2019041122403362400_R231","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jcem-51-5-1214","article-title":"Pregnancies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump (\u201cZyklomat\u201d)\u2014a new approach to the treatment of infertility in hypothalamic amenorrhea.","volume":"51","author":"Leyendecker","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R232","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.med.45.1.391","article-title":"Gonadotropin-releasing hormone and its analogs.","volume":"45","author":"Conn","year":"1994","journal-title":"Annu Rev Med"},{"key":"2019041122403362400_R233","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01806244","article-title":"Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma.","volume":"7","author":"Santen","year":"1986","journal-title":"Breast Cancer Res Treat"},{"key":"2019041122403362400_R234","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/jcem-52-5-882","article-title":"Pregnancy after prolonged pulsatile administration of luteinizing hormone-releasing hormone in a patient with clomiphene-resistant secondary amenorrhea.","volume":"52","author":"Schoemaker","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R235","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(84)92840-X","article-title":"Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.","volume":"2","author":"Porter","year":"1984","journal-title":"Lancet"},{"key":"2019041122403362400_R236","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1471-0528.1982.tb04642.x","article-title":"A new systematic treatment for infertile women with abnormal hormone profiles.","volume":"89","author":"Fleming","year":"1982","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041122403362400_R237","first-page":"20","article-title":"Management of unsatisfactory superovulation responses in an IVF programme.","volume":"1","author":"Healy","year":"1986","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R238","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0140-6736(85)90444-1","article-title":"Twin pregnancy after pituitary desensitisation with LHRH agonist and pure FSH.","volume":"2","author":"Shaw","year":"1985","journal-title":"Lancet"},{"key":"2019041122403362400_R239","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02989939","article-title":"The uses of LH-releasing hormone and analogs in infertility.","volume":"155","author":"Fleming","year":"1986","journal-title":"Ir J Med Sci"},{"key":"2019041122403362400_R240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.humrep.a136334","article-title":"Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.","volume":"1","author":"Wildt","year":"1986","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R241","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.humrep.a136750","article-title":"The luteal phase and early pregnancy after combined GnRH-agonist\/HMG treatment for superovulation in IVF or GIFT.","volume":"3","author":"Smitz","year":"1988","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R242","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1210\/endo.135.5.7956897","article-title":"Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells.","volume":"135","author":"Peng","year":"1994","journal-title":"Endocrinology"},{"key":"2019041122403362400_R243","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.fertnstert.2005.02.011","article-title":"Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?","volume":"83","author":"Fauser","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R244","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1210\/endo.140.8.6899","article-title":"The role of gonadotropin-releasing hormone in murine preimplantation embryonic development.","volume":"140","author":"Raga","year":"1999","journal-title":"Endocrinology"},{"key":"2019041122403362400_R245","first-page":"1377","article-title":"Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation.","volume":"85","author":"Casan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R246","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0015-0282(00)01632-0","article-title":"Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix.","volume":"75","author":"Ludwig","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R247","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/humrep\/13.9.2362","article-title":"Future use of clomiphene in ovarian stimulation. Clomiphene in the 21st century.","volume":"13","author":"Messinis","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R248","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/humrep\/16.4.696","article-title":"A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate.","volume":"16","author":"Ingerslev","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R249","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.humrep.a136039","article-title":"Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction.","volume":"10","author":"Dhont","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R250","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/17.8.2022","article-title":"Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to \u2018friendly IVF\u2019?","volume":"17","author":"Engel","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R251","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0015-0282(01)03265-4","article-title":"Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.","volume":"77","author":"Tavaniotou","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R252","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0015-0282(02)03374-5","article-title":"Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist.","volume":"78","author":"Williams","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R253","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-0528.1995.tb09139.x","article-title":"In vitro fertilisation and gamete intrafallopian transfer: an integrative analysis of research, 1987\u20131992.","volume":"102","author":"Kenny","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041122403362400_R254","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)47597-7","article-title":"Treatment of infertile women with a deficient postcoital test with two antiestrogens: clomiphene and tamoxifen.","volume":"41","author":"Roumen","year":"1984","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/6.3.207","article-title":"Modulation of the oestrogen receptor: a process with distinct susceptible steps.","volume":"6","author":"Cano","year":"2000","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R256","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deg045","article-title":"Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.","volume":"18","author":"Oktay","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R257","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019041122403362400_R258","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.humrep.a138053","article-title":"Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study.","volume":"8","author":"Hooff","year":"1993","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R259","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/14.10.2442","article-title":"A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation.","volume":"14","author":"Hoomans","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/humrep\/15.1.29","article-title":"Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation.","volume":"15","author":"Out","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R261","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/humrep\/16.6.1104","article-title":"A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles.","volume":"16","author":"Out","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R262","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0015-0282(01)02844-8","article-title":"A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization.","volume":"76","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R263","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0015-0282(02)04583-1","article-title":"A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment.","volume":"79","author":"Yong","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R264","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/humrep\/16.8.1676","article-title":"A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF\/ICSI.","volume":"16","author":"Wikland","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/humupd\/dmg007","article-title":"Clinical management of low ovarian response to stimulation for IVF: a systematic review.","volume":"9","author":"Tarlatzis","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R266","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R267","article-title":"\u201cCoasting\u201d (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.","author":"D\u2019Angelo","year":"2002","journal-title":"Cochrane Database Syst"},{"key":"2019041122403362400_R268","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0015-0282(16)55624-6","article-title":"Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489) in gonadotropin-deficient volunteers.","volume":"59","author":"Mannaerts","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R269","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0015-0282(98)00018-1","article-title":"Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle.","volume":"69","author":"Rombauts","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R270","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0015-0282(01)03246-0","article-title":"Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.","volume":"77","author":"Daya","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R271","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/humrep\/16.12.2563","article-title":"Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK.","volume":"16","author":"Daya","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R272","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1093\/humrep\/16.12.2557","article-title":"The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments.","volume":"16","author":"Sykes","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R273","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0015-0282(99)00519-1","article-title":"Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis.","volume":"73","author":"Agrawal","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R274","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0015-0282(02)03131-X","article-title":"Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-\u03b2 for in vitro fertilization: a prospective, randomized study.","volume":"77","author":"Dickey","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R275","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(02)03250-8","article-title":"Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization\/intracytoplasmic sperm injection cycles: a randomized, comparative trial.","volume":"78","author":"Isreal","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R276","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0015-0282(03)02187-3","article-title":"Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.","volume":"80","author":"Wely","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R277","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/humrep\/deg088","article-title":"Meta-analysis of recombinant versus urinary-derived FSH: an update.","volume":"18","author":"Al Inany","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R278","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/oxfordjournals.humrep.a019459","article-title":"Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin.","volume":"11","author":"Albano","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R279","doi-asserted-by":"crossref","first-page":"31479","DOI":"10.1074\/jbc.C100278200","article-title":"A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases.","volume":"276","author":"Shaked","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041122403362400_R280","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/humrep\/17.7.1675","article-title":"The use of urinary gonadotrophins should be discouraged.","volume":"17","author":"Matorras","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R281","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/humrep\/deh175","article-title":"Creutzfeldt-Jakob disease and urinary gonadotrophins.","volume":"19","author":"Ward","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R282","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/humrep\/16.8.1592","article-title":"First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.","volume":"16","author":"Bouloux","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R283","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/humrep\/17.8.1987","article-title":"Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.","volume":"17","author":"Duijkers","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R284","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0015-0282(02)04804-5","article-title":"First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization.","volume":"79","author":"Beckers","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R285","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin \u03b1) for controlled ovarian stimulation before in vitro fertilization.","volume":"89","author":"Devroey","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R286","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","article-title":"Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction.","volume":"15","author":"Westergaard","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R287","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/humrep\/15.7.1440","article-title":"Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH.","volume":"15","author":"Fleming","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R288","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/humrep\/15.11.2258","article-title":"The role of LH in ovarian stimulation: exogenous LH: let\u2019s design the future.","volume":"15","author":"Levy","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R289","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2001.tb03789.x","article-title":"Gonadotropin-releasing hormone antagonists implications for oocyte quality and uterine receptivity.","volume":"943","author":"Gordon","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"2019041122403362400_R290","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0015-0282(02)03157-6","article-title":"The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation.","volume":"77","author":"Shoham","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R291","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0015-0282(02)03372-1","article-title":"Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization.","volume":"78","author":"Commenges-Ducos","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R292","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humrep\/deh625","article-title":"Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.","volume":"20","author":"De Placido","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R293","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/deh741","article-title":"Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.","volume":"20","author":"Griesinger","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R294","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.fertnstert.2004.07.969","article-title":"Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization.","volume":"83","author":"Lisi","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R295","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humupd\/dmi030","article-title":"Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review.","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R296","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0015-0282(99)00426-4","article-title":"Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea.","volume":"72","author":"Filicori","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R297","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/deg066","article-title":"Clinical evidence for an LH \u2018ceiling\u2019 effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation.","volume":"18","author":"Loumaye","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R298","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2005-872452","article-title":"In vitro maturation of oocytes.","volume":"23","author":"Rao","year":"2005","journal-title":"Semin Reprod Med"},{"key":"2019041122403362400_R299","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/humrep\/deh682","article-title":"Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study.","volume":"20","author":"Hugues","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R300","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.fertnstert.2005.02.036","article-title":"Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.","volume":"84","author":"Filicori","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R301","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1023\/A:1016662100572","article-title":"The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction.","volume":"18","author":"Balasch","year":"2001","journal-title":"J Assist Reprod Genet"},{"key":"2019041122403362400_R302","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/humrep\/deg506","article-title":"LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.","volume":"18","author":"Penarrubia","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R303","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/humrep\/deh471","article-title":"Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF.","volume":"19","author":"Kolibianakis","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R304","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2003.11.040","article-title":"Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer.","volume":"82","author":"Merviel","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R305","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fertnstert.2004.06.050","article-title":"Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.","volume":"83","author":"Cabrera","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R306","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)02847-3","article-title":"Differential dose of antagonist (Ganirelix) relative to exogenous FSH.","volume":"76","author":"Al Inany","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R307","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1210\/jc.2003-030805","article-title":"Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.","volume":"88","author":"Kolibianakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R308","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/humrep\/15.11.2333","article-title":"Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study.","volume":"15","author":"Janssens","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R309","first-page":"249","article-title":"Assisted reproduction\u2014in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues.","volume":"20","author":"Barbieri","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041122403362400_R310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/humupd\/4.1.83","article-title":"Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins.","volume":"4","author":"Hugues","year":"1998","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R311","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003495-200464030-00005","article-title":"Contemporary pharmacological manipulation in assisted reproduction.","volume":"64","author":"Huirne","year":"2004","journal-title":"Drugs"},{"key":"2019041122403362400_R312","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/oxfordjournals.bmb.a072426","article-title":"Endocrinology in luteal phase and implantation.","volume":"46","author":"Smitz","year":"1990","journal-title":"Br Med Bull"},{"key":"2019041122403362400_R313","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/oxfordjournals.humrep.a137976","article-title":"Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.","volume":"8","author":"Donderwinkel","year":"1993","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R314","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/oxfordjournals.humrep.a137800","article-title":"The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women.","volume":"7","author":"Smitz","year":"1992","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R315","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/humrep\/15.5.1009","article-title":"Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization.","volume":"15","author":"Cedrin-Durnerin","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R316","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/humrep\/15.11.2292","article-title":"High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial.","volume":"15","author":"Garcia-Velasco","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R317","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humrep\/15.1.43","article-title":"Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.","volume":"15","author":"Beckers","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R318","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001299","article-title":"Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.","author":"Daya","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041122403362400_R319","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.humrep.a136889","article-title":"Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle.","volume":"4","author":"Pellicer","year":"1989","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R320","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0015-0282(16)55322-9","article-title":"A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.","volume":"58","author":"San Roman","year":"1992","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R321","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0015-0282(16)55636-2","article-title":"No detrimental effects in delaying initiation of gonadotropin administration after pituitary desensitization with gonadotropin-releasing hormone agonist.","volume":"59","author":"Chang","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R322","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/oxfordjournals.humrep.a137466","article-title":"Beneficial effects of a 24 h delay in human chorionic gonadotrophin administration during in-vitro fertilization treatment cycles.","volume":"6","author":"Dimitry","year":"1991","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R323","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation.","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R324","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/13.9.2411","article-title":"The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg.","volume":"13","author":"Olivennes","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R325","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","article-title":"A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group.","volume":"13","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R326","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R327","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.","volume":"15","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R328","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R329","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R330","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.","volume":"16","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R331","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: a Cochrane review.","volume":"17","author":"Al Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R332","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1067\/S0002-9378(03)00489-7","article-title":"The use of gonadotropin-releasing hormone antagonist in a flexible protocol: a pilot study.","volume":"189","author":"Mansour","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122403362400_R333","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deh044","article-title":"A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction.","volume":"19","author":"Out","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R334","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S1472-6483(10)61098-X","article-title":"Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial.","volume":"8","author":"Aboulghar","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"2019041122403362400_R335","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/humrep\/deh369","article-title":"Recombinant human LH supplementation during GnRH antagonist administration in IVF\/ICSI cycles: a prospective randomized study.","volume":"19","author":"Cedrin-Durnerin","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R336","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.","volume":"88","author":"Hohmann","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R337","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/humrep\/15.1.165","article-title":"Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.","volume":"15","author":"Chian","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R338","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1093\/humrep\/14.9.2242","article-title":"High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.","volume":"14","author":"Kol","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R339","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0015-0282(01)03008-4","article-title":"Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle.","volume":"77","author":"Seelig","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jcem-33-6-917","article-title":"The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function.","volume":"33","author":"Tsai","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R341","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1210\/jcem-32-4-503","article-title":"New evidence for an anti-estrogenic action of clomiphene citrate in women.","volume":"32","author":"Vaitukaitis","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R342","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/endo-109-2-352","article-title":"Premature elevation of systemic estradiol reduces serum levels of follicle-stimulating hormone and lengthens the follicular phase of the menstrual cycle in rhesus monkeys.","volume":"109","author":"Zeleznik","year":"1981","journal-title":"Endocrinology"},{"key":"2019041122403362400_R343","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(16)53282-8","article-title":"Gonadotropin suppression with oral contraceptives before in vitro fertilization.","volume":"53","author":"Gonen","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R344","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0015-0282(16)49644-5","article-title":"A new approach to follicular stimulation for in vitro fertilization: programed oocyte retrieval.","volume":"46","author":"Frydman","year":"1986","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.1988.tb22240.x","article-title":"Protocols for induction of ovulation. The concept of programmed cycles.","volume":"541","author":"Mashiach","year":"1988","journal-title":"Ann NY Acad Sci"},{"key":"2019041122403362400_R346","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0015-0282(16)60315-1","article-title":"An increased initial follicle-stimulating hormone\/luteinizing hormone ratio does not affect ovarian responses and the outcomes of in vitro fertilization.","volume":"50","author":"Benadiva","year":"1988","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R347","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.1984.tb05899.x","article-title":"The recovery of pre-ovulatory oocytes using a fixed schedule of ovulation induction and follicle aspiration.","volume":"91","author":"Templeton","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041122403362400_R348","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2002-36713","article-title":"GnRH agonists, antagonists, and assisted conception.","volume":"20","author":"Loenen","year":"2002","journal-title":"Semin Reprod Med"},{"key":"2019041122403362400_R349","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1988.tb22239.x","article-title":"Improvements in ovarian stimulation for in vitro fertilization.","volume":"541","author":"Frydman","year":"1988","journal-title":"Ann NY Acad Sci"},{"key":"2019041122403362400_R350","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/deg516","article-title":"Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists.","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R351","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000293552","article-title":"Gonadotropin and ovarian steroid production in polycystic ovarian syndrome during suppression with a gonadotropin-releasing hormone agonist.","volume":"28","author":"Tanbo","year":"1989","journal-title":"Gynecol Obstet Invest"},{"key":"2019041122403362400_R352","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","article-title":"Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.","volume":"12","author":"Damario","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R353","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin.","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041122403362400_R354","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/0140-6736(91)91512-S","article-title":"Effects of in-utero exposure to oral hypoglycaemic drugs.","volume":"338","author":"Piacquadio","year":"1991","journal-title":"Lancet"},{"key":"2019041122403362400_R355","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/humrep\/17.8.1950","article-title":"Should patients with polycystic ovarian syndrome be treated with metformin? An enthusiastic endorsement.","volume":"17","author":"Nestler","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R356","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R357","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors.","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R358","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/gye.17.3.207.214","article-title":"The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial.","volume":"17","author":"Fedorcsak","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"2019041122403362400_R359","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/humrep\/deh248","article-title":"Metformin treatment before IVF\/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.","volume":"19","author":"Kjotrod","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R360","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM200309113491117","article-title":"Aromatase inhibitors in breast cancer.","volume":"349","author":"Forrest","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041122403362400_R361","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/(SICI)1099-081X(199708)18:6<489::AID-BDD36>3.0.CO;2-P","article-title":"Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration.","volume":"18","author":"Sioufi","year":"1997","journal-title":"Biopharm Drug Dispos"},{"key":"2019041122403362400_R362","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate.","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R363","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/jm00173a001","article-title":"Mechanism and inhibition of cytochrome P-450 aromatase.","volume":"33","author":"Cole","year":"1990","journal-title":"J Med Chem"},{"key":"2019041122403362400_R364","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0960-0760(97)80008-8","article-title":"Effect of estrogen deprivation on the reproductive physiology of male and female primates.","volume":"61","author":"Shetty","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122403362400_R365","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R366","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/1097-0142(19950415)75:8<2132::AID-CNCR2820750816>3.0.CO;2-U","article-title":"Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.","volume":"75","author":"Lipton","year":"1995","journal-title":"Cancer"},{"key":"2019041122403362400_R367","first-page":"266","article-title":"Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer.","volume":"53","author":"Iveson","year":"1993","journal-title":"Cancer Res"},{"key":"2019041122403362400_R368","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jsgi.2004.03.006","article-title":"Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.","volume":"11","author":"Mitwally","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"2019041122403362400_R369","first-page":"61","article-title":"In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells.","volume":"77","author":"Barreca","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R370","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2265.1999.00831.x","article-title":"GH substitution does not alter the pulsatile pattern of LH in amenorrhoeic growth hormone deficient women.","volume":"51","author":"Boer","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122403362400_R371","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/humrep\/14.8.1939","article-title":"Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?","volume":"14","author":"Howles","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R372","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2265.1997.1800999.x","article-title":"Impaired reproductive function in women treated for growth hormone deficiency during childhood.","volume":"46","author":"Boer","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122403362400_R373","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000099","article-title":"Growth hormone for in vitro fertilization.","author":"Harper","year":"2003","journal-title":"Cochrane Database Syst Rev CD000099"},{"key":"2019041122403362400_R374","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/oxfordjournals.humrep.a138381","article-title":"Ovarian stimulation in an infertile patient with growth hormone-deficient Oliver-Mcfarlane syndrome.","volume":"9","author":"Shaker","year":"1994","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R375","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.humrep.a137403","article-title":"Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation?","volume":"6","author":"Menashe","year":"1991","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R376","first-page":"539","article-title":"Insulin-like growth factor-I (IGF-I) may not be essential for ovarian follicular development: evidence from IGF-I deficiency.","volume":"74","author":"Dor","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R377","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.fertnstert.2004.03.026","article-title":"Ovulation induction and successful pregnancy outcome in two patients with Prop1 gene mutations.","volume":"82","author":"Voutetakis","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R378","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0950-3552(97)80036-3","article-title":"Role of androgens in follicle maturation and atresia.","volume":"11","author":"Hillier","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"2019041122403362400_R379","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of clinical outcomes of conventional IVF in polycystic ovary syndrome women who failed to conceive during ovulation induction.","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R380","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.fertnstert.2003.11.032","article-title":"Effect of androgen levels on in vitro fertilization cycles.","volume":"81","author":"Frattarelli","year":"2004","journal-title":"Fertil Steril"},{"issue":"(Suppl 1)","key":"2019041122403362400_R381","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/humrep\/11.suppl_5.7","article-title":"What has happened? Where are we?","volume":"11","author":"Jones Jr","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R382","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0015-0282(16)53222-1","article-title":"Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.","volume":"53","author":"Herman","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R383","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0015-0282(16)53347-0","article-title":"Luteal rescue in in vitro fertilization-embryo transfer.","volume":"53","author":"Hutchinson-Williams","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R384","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00003081-199009000-00030","article-title":"Corpus luteum function and dysfunction.","volume":"33","author":"Stouffer","year":"1990","journal-title":"Clin Obstet Gynecol"},{"key":"2019041122403362400_R385","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0015-0282(16)56758-2","article-title":"The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials.","volume":"61","author":"Soliman","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R386","first-page":"211","article-title":"Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome.","volume":"47","author":"Delvigne","year":"2002","journal-title":"Int J Fertil Womens Med"},{"key":"2019041122403362400_R387","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0015-0282(01)02961-2","article-title":"Luteal phase support.","volume":"77","author":"Penzias","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R388","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0015-0282(16)56650-3","article-title":"Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program.","volume":"61","author":"Pantos","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R389","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/0002-9378(91)90037-R","article-title":"The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women.","volume":"165","author":"Ditkoff","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122403362400_R390","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00006254-200109000-00024","article-title":"Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review.","volume":"56","author":"Elter","year":"2001","journal-title":"Obstet Gynecol Surv"},{"key":"2019041122403362400_R391","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(98)00135-6","article-title":"The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix.","volume":"70","author":"Albano","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R392","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/14.6.1426","article-title":"Luteal phase and clinical outcome after human menopausal gonadotrophin\/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization\/intracytoplasmic sperm injection cycles.","volume":"14","author":"Albano","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R393","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(00)00414-3","article-title":"A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the \u201cfollicle-stimulating hormone window\u201d combined with the gonadotropin-releasing hormone antagonist cetrorelix.","volume":"73","author":"De Jong","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R394","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","article-title":"Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R395","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/humrep\/13.6.1461","article-title":"A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration.","volume":"13","author":"Mannaerts","year":"1998","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"2019041122403362400_R396","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1472-6483(11)60215-0","article-title":"Ovarian stimulation for IVF and endometrial receptivity\u2014the missing link","volume":"5","author":"Van Der Gaast","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"2019041122403362400_R397","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0378(01)00134-6","article-title":"Impact of ovarian stimulation on corpus luteum function and embryonic implantation.","volume":"55","author":"Tavaniotou","year":"2002","journal-title":"J Reprod Immunol"},{"key":"2019041122403362400_R398","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2001.tb03790.x","article-title":"Ovulation induction disrupts luteal phase function.","volume":"943","author":"Tavaniotou","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"2019041122403362400_R399","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/jcem-62-5-833","article-title":"Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.","volume":"62","author":"Stouffer","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R400","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2004.01.009","article-title":"Reproductive biology and IVF: ovarian stimulation and endometrial receptivity.","volume":"15","author":"Devroey","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"2019041122403362400_R401","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/humrep\/deh830","article-title":"GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.","volume":"20","author":"Pirard","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R402","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/oxfordjournals.humrep.a137831","article-title":"Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.","volume":"7","author":"Smitz","year":"1992","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"2019041122403362400_R403","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/humrep\/15.suppl_1.129","article-title":"Progesterone for the luteal support of assisted reproductive technologies: clinical options","volume":"15","author":"Posaci","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R404","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/humrep\/17.9.2287","article-title":"Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.","volume":"17","author":"Pritts","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R405","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0015-0282(16)59773-8","article-title":"A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer.","volume":"49","author":"Buvat","year":"1988","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R406","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/humrep\/14.8.1944","article-title":"Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration.","volume":"14","author":"Friedler","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R407","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/j.1600-0412.2001.080006574.x","article-title":"Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.","volume":"80","author":"Ludwig","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041122403362400_R408","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0015-0282(99)00632-9","article-title":"Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles.","volume":"73","author":"Farhi","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R409","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/oxfordjournals.humrep.a019453","article-title":"Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa\/HMG induced IVF cycles: a randomized clinical trial.","volume":"11","author":"Mochtar","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R410","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humrep\/17.2.357","article-title":"Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial.","volume":"17","author":"Nyboe","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R411","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0020-7292(99)00177-0","article-title":"Delayed luteo-placental shift of progesterone production in IVF pregnancy.","volume":"68","author":"Costea","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"2019041122403362400_R412","first-page":"1198","article-title":"Total estradiol and progesterone receptor levels and DNA concentrations in human endometrium with nonuniform postovulatory delay of maturation.","volume":"23","author":"Gorodeski","year":"1987","journal-title":"Isr J Med Sci"},{"key":"2019041122403362400_R413","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0015-0282(16)60729-X","article-title":"Luteal cytoplasmic estradiol and progesterone receptors in human endometrium: in vitro fertilization and normal cycles.","volume":"51","author":"Molina","year":"1989","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R414","first-page":"2405","article-title":"Ovulation induction and endometrial steroid receptors.","volume":"9","author":"Hadi","year":"1994","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R415","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0015-0282(16)56647-3","article-title":"Endometrial structure after superovulation: a prospective controlled study.","volume":"61","author":"Macrow","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R416","first-page":"101","article-title":"Impact of ovarian hyperstimulation on the luteal phase.","volume":"55","author":"Macklon","year":"2000","journal-title":"J Reprod Fertil Suppl"},{"key":"2019041122403362400_R417","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1210\/jcem-64-3-472","article-title":"Endometrial cytosolic and nuclear progesterone receptors in the luteal phase defect.","volume":"64","author":"Jacobs","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R418","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0015-0282(02)03323-X","article-title":"Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.","volume":"78","author":"Kolibianakis","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R419","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1073\/pnas.0530162100","article-title":"Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation.","volume":"100","author":"Ma","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122403362400_R420","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0015-0282(16)54236-8","article-title":"Secretory changes in preovulatory endometrium during controlled ovarian hyperstimulation with buserelin acetate and human gonadotropins.","volume":"55","author":"Marchini","year":"1991","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R421","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0015-0282(97)80080-5","article-title":"Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase.","volume":"67","author":"Ubaldi","year":"1997","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R422","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/humrep\/16.3.435","article-title":"Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation.","volume":"16","author":"Basir","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R423","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0015-0282(02)04920-8","article-title":"Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.","volume":"79","author":"Kolibianakis","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R424","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/humrep\/10.1.4","article-title":"Hormonal control of endometrial receptivity.","volume":"10","author":"Ziegler","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R425","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/humrep\/dei069","article-title":"Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles.","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R426","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0015-0282(99)00447-1","article-title":"Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study.","volume":"73","author":"Gerli","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R427","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1210\/jc.2004-0605","article-title":"Gene expression profiles and structural\/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles.","volume":"89","author":"Mirkin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R428","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/molehr\/gah150","article-title":"Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles.","volume":"11","author":"Horcajadas","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"2019041122403362400_R429","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/jrf.0.0960649","article-title":"Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice.","volume":"96","author":"Ertzeid","year":"1992","journal-title":"J Reprod Fertil"},{"key":"2019041122403362400_R430","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/humrep\/16.6.1237","article-title":"Superovulation of female mice delays embryonic and fetal development.","volume":"16","author":"Van der Auwera","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R431","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/16.2.221","article-title":"The impact of ovarian stimulation on implantation and fetal development in mice.","volume":"16","author":"Ertzeid","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R432","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1095\/biolreprod36.2.439","article-title":"Cell surface characteristics of blastocysts from spontaneously ovulating and gonadotropin-treated mice.","volume":"36","author":"Champlin","year":"1987","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R433","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/jrf.0.0450437","article-title":"Embryonic mortality during the pre- and post-implantation periods of pregnancy in mature mice after superovulation.","volume":"45","author":"Beaumont","year":"1975","journal-title":"J Reprod Fertil"},{"key":"2019041122403362400_R434","doi-asserted-by":"crossref","first-page":"E845","DOI":"10.1152\/ajpendo.00398.2004","article-title":"Effects of recombinant human follicle-stimulating hormone on embryo development in mice","volume":"288","author":"Edwards","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122403362400_R435","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-1161(85)90057-3","article-title":"Abnormal development and transport and increased sister chromatid exchange in preimplantation embryos following superovulation in mice.","volume":"147","author":"Ebling","year":"1985","journal-title":"Mutat Res"},{"key":"2019041122403362400_R436","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/266382b0","article-title":"Digynic triploidy after superovulation.","volume":"266","author":"Chang","year":"1977","journal-title":"Nature"},{"key":"2019041122403362400_R437","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(01)02018-0","article-title":"Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo.","volume":"76","author":"Valbuena","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R438","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1023\/A:1023670010031","article-title":"Oocyte and embryo quality in patients with excessive ovarian response during in vitro fertilization treatment.","volume":"20","author":"Ng","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"2019041122403362400_R439","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/humrep\/deh264","article-title":"Embryo quality in natural versus stimulated IVF cycles.","volume":"19","author":"Ziebe","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R440","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1095\/biolreprod59.6.1445","article-title":"Factors affecting the developmental competence of mouse oocytes grown in vitro: follicle-stimulating hormone and insulin.","volume":"59","author":"Eppig","year":"1998","journal-title":"Biol Reprod"},{"key":"2019041122403362400_R441","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0303-7207(99)00247-6","article-title":"Conditions that affect acquisition of developmental competence by mouse oocytes in vitro: FSH, insulin, glucose and ascorbic acid.","volume":"163","author":"Eppig","year":"2000","journal-title":"Mol Cell Endocrinol"},{"issue":"(Suppl 1)","key":"2019041122403362400_R442","first-page":"i91","article-title":"Does the magnitude of ovarian stimulation for IVF affect chromosomal competence of embryos as assessed by PGS?","volume":"20","author":"Baart","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R443","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0015-0282(98)00250-7","article-title":"Complications of medically assisted conception in 3,500 cycles.","volume":"70","author":"Serour","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R444","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/humrep\/14.11.2681","article-title":"Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks.","volume":"14","author":"Fauser","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R445","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/humrep\/14.10.2651","article-title":"Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow-up of 498 patients.","volume":"14","author":"Osmanagaoglu","year":"1999","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R446","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/humrep\/17.8.1994","article-title":"Metabolic characteristics of women who developed ovarian hyperstimulation syndrome.","volume":"17","author":"Delvigne","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R447","first-page":"211","article-title":"Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome.","volume":"47","author":"Delvigne","year":"2002","journal-title":"Int J Fertil Womens Med"},{"key":"2019041122403362400_R448","first-page":"1967","article-title":"Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.","volume":"80","author":"Neulen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R449","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/09513599909167573","article-title":"Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.","volume":"13","author":"D\u2019Ambrogio","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"2019041122403362400_R450","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humrep\/deh124","article-title":"New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?","volume":"19","author":"Delbaere","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R451","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0015-0282(00)00628-2","article-title":"A case of spontaneous ovarian hyperstimulation syndrome with a potential mutation in the hCG\/LH receptor gene.","volume":"74","author":"Akerman","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R452","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000410","article-title":"Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.","author":"Nugent","year":"2000","journal-title":"Cochrane Database Syst Rev CD000410"},{"key":"2019041122403362400_R453","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/humupd\/8.3.291","article-title":"A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients.","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R454","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS).","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R455","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.fertnstert.2004.05.005","article-title":"Ovarian hyperstimulation syndrome","volume":"82","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R456","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R457","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/humrep\/deh346","article-title":"Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation.","volume":"19","author":"Grandone","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R458","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/humrep\/12.10.2167","article-title":"Thromboembolic disease associated with ovarian stimulation and assisted conception techniques.","volume":"12","author":"Stewart","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R459","first-page":"3","author":"Macklon","year":"2005"},{"key":"2019041122403362400_R460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease.","volume":"90","author":"D\u2019Angelo","year":"1997","journal-title":"Blood"},{"key":"2019041122403362400_R461","first-page":"1017","article-title":"Successful assisted reproductive technology: the beauty of one.","volume":"100","author":"Hogue","year":"2002","journal-title":"Obstet Gynecol"},{"key":"2019041122403362400_R462","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0015-0282(02)04565-X","article-title":"Multiple births: how are we doing?","volume":"79","author":"Jones","year":"2003","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"2019041122403362400_R463","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.ejogrb.2003.09.005","article-title":"Characteristics of the childbearing population in Europe","volume":"111","author":"Breart","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041122403362400_R464","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/sper.2002.34775","article-title":"Trends in the occurrence, determinants, and consequences of multiple births.","volume":"26","author":"Blondel","year":"2002","journal-title":"Semin Perinatol"},{"key":"2019041122403362400_R465","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(99)04345-7","article-title":"Deliveries and children born after in-vitro fertilisation in Sweden 1982\u201395: a retrospective cohort study.","volume":"354","author":"Bergh","year":"1999","journal-title":"Lancet"},{"key":"2019041122403362400_R466","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/humrep\/15.8.1856","article-title":"Multiple gestation pregnancy. The ESHRE Capri Workshop Group.","volume":"15","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R467","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/humrep\/deh392","article-title":"What is the most relevant standard of success in assisted reproduction? Singleton live births should also include preterm births.","volume":"19","author":"Wennerholm","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R468","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.0001-6349.2004.00476.x","article-title":"Neonatal outcome in a Danish national cohort of 8602 children born after in vitro fertilization or intracytoplasmic sperm injection: the role of twin pregnancy.","volume":"83","author":"Pinborg","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041122403362400_R469","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1056\/NEJMoa010856","article-title":"Outcomes in young adulthood for very-low-birth-weight infants.","volume":"346","author":"Hack","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041122403362400_R470","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2001-15505","article-title":"Maternal and neonatal outcome of 100 consecutive triplet pregnancies.","volume":"18","author":"Devine","year":"2001","journal-title":"Am J Perinatol"},{"key":"2019041122403362400_R471","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.jp.7200492","article-title":"Morbidity and mortality of preterm twins and higher-order multiple births.","volume":"21","author":"Suri","year":"2001","journal-title":"J Perinatol"},{"key":"2019041122403362400_R472","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000059372","article-title":"Multifetal gestation\u2013maternal and perinatal outcome of 112 pregnancies.","volume":"17","author":"Strauss","year":"2002","journal-title":"Fetal Diagn Ther"},{"key":"2019041122403362400_R473","first-page":"449","article-title":"Intertwin birth weight discordance as a potential adaptive measure to promote gestational age.","volume":"48","author":"Blickstein","year":"2003","journal-title":"J Reprod Med"},{"key":"2019041122403362400_R474","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa010806","article-title":"Low and very low birth weight in infants conceived with use of assisted reproductive technology.","volume":"346","author":"Schieve","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041122403362400_R475","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2105\/AJPH.92.8.1323","article-title":"The impact of the increasing number of multiple births on the rates of preterm birth and low birthweight: an international study.","volume":"92","author":"Blondel","year":"2002","journal-title":"Am J Public Health"},{"key":"2019041122403362400_R476","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bmj.37957.560278.EE","article-title":"Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies.","volume":"328","author":"Helmerhorst","year":"2004","journal-title":"BMJ"},{"key":"2019041122403362400_R477","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.AOG.0000114989.84822.51","article-title":"Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis.","volume":"103","author":"Jackson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2019041122403362400_R478","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(03)13592-1","article-title":"Rare congenital disorders, imprinted genes, and assisted reproductive technology.","volume":"361","author":"Gosden","year":"2003","journal-title":"Lancet"},{"issue":"(Suppl)","key":"2019041122403362400_R479","doi-asserted-by":"crossref","first-page":"s29","DOI":"10.1038\/ncb-nm-fertilityS29","article-title":"The economic impact of the assisted reproductive technologies.","volume":"4","author":"Katz","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2019041122403362400_R480","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0015-0282(01)03243-5","article-title":"A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer.","volume":"77","author":"Hunault","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R481","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.fertnstert.2004.06.031","article-title":"Guidelines on the number of embryos transferred.","volume":"82","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R482","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/oxfordjournals.humrep.a019231","article-title":"What\u2019s your success rate? Dr. X comes to America.","volume":"11","author":"Schulman","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R483","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humrep\/deh028","article-title":"What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.","volume":"19","author":"Min","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R484","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/humupd\/8.3.265","article-title":"An international survey of the health economics of IVF and ICSI.","volume":"8","author":"Collins","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/8.1.1","article-title":"Alternative approaches in IVF.","volume":"8","author":"Fauser","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R486","first-page":"947","article-title":"Gaps in the evidence for fertility treatment\u2014an analysis of the Cochrane Menstrual Disorders and Subfertility Group database.","volume":"18","author":"Johnson","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R487","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/humrep\/deh368","article-title":"What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment.","volume":"19","author":"Heijnen","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R488","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1008921211309","article-title":"Cancer risk associated with subfertility and ovulation induction: a review.","volume":"11","author":"Klip","year":"2000","journal-title":"Cancer Causes Control"},{"key":"2019041122403362400_R489","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/humrep\/deg358","article-title":"Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women.","volume":"18","author":"Klip","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R490","first-page":"1325","article-title":"Gonadotropin-induced gene regulation in human granulosa cells obtained from IVF patients: modulation of genes coding for growth factors and their receptors and genes involved in cancer and other diseases.","volume":"24","author":"Rimon","year":"2004","journal-title":"Int J Oncol"},{"key":"2019041122403362400_R491","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/oxfordjournals.humrep.a137041","article-title":"In-vitro fertilization: influence of women\u2019s age on pregnancy rates.","volume":"5","author":"Piette","year":"1990","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R492","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1071\/RD9950229","article-title":"Factors affecting success with intracytoplasmic sperm injection.","volume":"7","author":"Tucker","year":"1995","journal-title":"Reprod Fertil Dev"},{"key":"2019041122403362400_R493","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0301-2115(96)02396-2","article-title":"The impact of woman\u2019s age and sperm parameters on fertilization rates in IVF cycles.","volume":"66","author":"Ashkenazi","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041122403362400_R494","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0015-0282(16)58214-4","article-title":"The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization.","volume":"65","author":"Hull","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R495","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0015-0282(16)58035-2","article-title":"Achieving multiple-order embryo transfer identifies women over 40 years of age with improved in vitro fertilization outcome.","volume":"65","author":"Widra","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R496","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(96)05291-9","article-title":"Factors that affect outcome of in-vitro fertilisation treatment.","volume":"348","author":"Templeton","year":"1996","journal-title":"Lancet"},{"key":"2019041122403362400_R497","first-page":"76","article-title":"ART in women 40 and over. Is the cost worth it?","volume":"42","author":"Legro","year":"1997","journal-title":"J Reprod Med"},{"key":"2019041122403362400_R498","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM198202183060706","article-title":"Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS.","volume":"306","author":"Schwartz","year":"1982","journal-title":"N Engl J Med"},{"key":"2019041122403362400_R499","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0015-0282(02)02972-2","article-title":"A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause.","volume":"77","author":"De Boer","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R500","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humrep\/deg101","article-title":"Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis.","volume":"18","author":"Lawson","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R501","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/humupd\/dmi006","article-title":"Fertility and ageing.","volume":"11","author":"Baird","year":"2005","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R502","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/humrep\/deg245","article-title":"Early ovarian ageing: a hypothesis. Detection and clinical relevance.","volume":"18","author":"Nikolaou","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R503","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0015-0282(02)03227-2","article-title":"Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging.","volume":"78","author":"Beckers","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R504","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0015-0282(98)00040-5","article-title":"Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders.","volume":"69","author":"Faber","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R505","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0015-0282(97)00575-X","article-title":"Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.","volume":"69","author":"Surrey","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R506","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.fertnstert.2004.11.005","article-title":"The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization.","volume":"83","author":"Klinkert","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R507","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/humrep\/deh622","article-title":"\u2019Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome\u2019.","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R508","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial.","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R509","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/humupd\/6.4.307","article-title":"Regulation of follicle development and novel approaches to ovarian stimulation for IVF.","volume":"6","author":"Macklon","year":"2000","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/humupd\/8.2.129","article-title":"Efficacy of natural cycle IVF: a review of the literature.","volume":"8","author":"Pelinck","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R511","first-page":"1292","article-title":"The follicle-stimulating hormone (FSH) threshold\/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.","volume":"83","author":"Schipper","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R512","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/humrep\/16.5.846","article-title":"Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development.","volume":"16","author":"Hohmann","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R513","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1210\/endo-117-3-991","article-title":"Interference with the gonadotropin-suppressing actions of estradiol in macaques overrides the selection of a single preovulatory follicle.","volume":"117","author":"Zeleznik","year":"1985","journal-title":"Endocrinology"},{"key":"2019041122403362400_R514","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1210\/endo-119-5-2025","article-title":"Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH.","volume":"119","author":"Zeleznik","year":"1986","journal-title":"Endocrinology"},{"key":"2019041122403362400_R515","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-57-4-792","article-title":"Hormonal dynamics at midcycle: a reevaluation.","volume":"57","author":"Hoff","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R516","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)57717-6","article-title":"The luteinizing hormone surge\u2013the final stage in ovulation induction: modern aspects of ovulation triggering.","volume":"64","author":"Shoham","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R517","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)60906-8","article-title":"Disappearance of exogenously administered human chorionic gonadotropin.","volume":"52","author":"Damewood","year":"1989","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R518","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R519","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist.","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R520","first-page":"298","article-title":"Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge.","volume":"79","author":"Chandrasekher","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R521","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0015-0282(98)00140-X","article-title":"Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.","volume":"70","author":"Simon","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R522","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study.","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R523","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2004-2169","article-title":"A prospective, randomized, double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase.","volume":"90","author":"Chan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122403362400_R524","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.humrep.a138497","article-title":"Direct assessment of the rate of chromosomal abnormalities in grade IV human embryos produced by in-vitro fertilization procedure.","volume":"9","author":"Pellestor","year":"1994","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R525","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/humrep\/12.4.780","article-title":"Treatment-related chromosome abnormalities in human embryos.","volume":"12","author":"Munne","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R526","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s004390050443","article-title":"Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients.","volume":"99","author":"Delhanty","year":"1997","journal-title":"Hum Genet"},{"key":"2019041122403362400_R527","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/8.4.333","article-title":"Conception to ongoing pregnancy: the \u2018black box\u2019 of early pregnancy loss.","volume":"8","author":"Macklon","year":"2002","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R528","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1093\/humrep\/deh536","article-title":"Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial.","volume":"19","author":"Staessen","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R529","first-page":"1","article-title":"Cytogenetics of pregnancy wastage.","volume":"14","author":"Boue","year":"1985","journal-title":"Adv Hum Genet"},{"key":"2019041122403362400_R530","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2004.06.071","article-title":"Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages.","volume":"83","author":"Platteau","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R531","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/humupd\/dmh005","article-title":"The development of cytogenetically normal, abnormal and mosaic embryos: a theoretical model.","volume":"10","author":"Los","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041122403362400_R532","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0015-0282(16)57739-5","article-title":"Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities.","volume":"64","author":"Munne","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R533","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/humrep\/17.2.413","article-title":"Chromosomal mosaicism throughout human preimplantation development in vitro: incidence, type, and relevance to embryo outcome.","volume":"17","author":"Bielanska","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R534","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humrep\/deh094","article-title":"Fluorescence in situ hybridization analysis of two blastomeres from day 3 frozen-thawed embryos followed by analysis of the remaining embryo on day 5.","volume":"19","author":"Baart","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R535","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/humrep\/dei291","article-title":"Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF.","volume":"21","author":"Baart","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R536","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/oxfordjournals.humrep.a138162","article-title":"Assessment of polyploidy in human morulae and blastocysts using co-culture and fluorescent in-situ hybridization.","volume":"8","author":"Benkhalifa","year":"1993","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R537","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/humrep\/15.2.440","article-title":"Fluorescence in-situ hybridization of sex chromosomes in spermatozoa and spare preimplantation embryos of a Klinefelter 46,XY\/47,XXY male.","volume":"15","author":"Bielanska","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041122403362400_R538","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1097-0223(200007)20:7<552::AID-PD871>3.0.CO;2-F","article-title":"FISH analysis on day 5 post-insemination of human arrested and blastocyst stage embryos.","volume":"20","author":"Ruangvutilert","year":"2000","journal-title":"Prenat Diagn"},{"key":"2019041122403362400_R539","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s004390051030","article-title":"Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization.","volume":"106","author":"Voullaire","year":"2000","journal-title":"Hum Genet"},{"key":"2019041122403362400_R540","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/molehr\/6.11.1055","article-title":"Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization.","volume":"6","author":"Wells","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"2019041122403362400_R541","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.62.5.665","article-title":"The comparative behavior of mammalian eggs in vivo and in vitro. I. The activation of ovarian eggs.","volume":"62","author":"Pincus","year":"1935","journal-title":"J Exp Med"},{"key":"2019041122403362400_R542","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(65)92903-X","article-title":"Maturation in vitro of human ovarian oocytes.","volume":"2","author":"Edwards","year":"1965","journal-title":"Lancet"},{"key":"2019041122403362400_R543","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/221632a0","article-title":"Early stages of fertilization in vitro of human oocytes matured in vitro.","volume":"221","author":"Edwards","year":"1969","journal-title":"Nature"},{"key":"2019041122403362400_R544","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0015-0282(16)47052-4","article-title":"Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization.","volume":"39","author":"Veeck","year":"1983","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R545","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0015-0282(16)56891-5","article-title":"In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients.","volume":"62","author":"Trounson","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R546","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0015-0282(00)00422-2","article-title":"Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome.","volume":"73","author":"Cha","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041122403362400_R547","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/rep.0.1220587","article-title":"Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study.","volume":"122","author":"Mikkelsen","year":"2001","journal-title":"Reproduction"},{"key":"2019041122403362400_R548","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJM199911183412118","article-title":"Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome.","volume":"341","author":"Chian","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/27\/2\/170\/10335828\/edrv0170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T23:14:18Z","timestamp":1683414858000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/27\/2\/170\/2355253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":548,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2005-0015","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,1]]}}}